Premium
RESPONSE ORIENTED MAINTENANCE THERAPY IN ADVANCED FOLLICULAR LYMPHOMA. RESULTS OF THE INTERIM ANALYSIS OF THE FOLL12 TRIAL CONDUCTED BY THE FONDAZIONE ITALIANA LINFOMI.
Author(s) -
Federico M.,
Mannina D.,
Versari A.,
Ferrero S.,
Marcheselli L.,
Boccomini C.,
Dondi A.,
Tucci A.,
Guerra L.,
Galimberti S.,
Cavallo F.,
Olivieri J.,
Corradini P.,
Arcaini L.,
Chauvie S.,
Del Giudice I.,
Rusconi C.,
Pinto A.,
Molinari A.,
Pulsoni A.,
Merli M.,
Kovalchuk S.,
Nassi L.,
Bolis S.,
Gattei V.,
Manni M.,
Pileri S.,
Brugiatelli M.,
Luminari S.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.110_2629
Subject(s) - rituximab , medicine , follicular lymphoma , interim analysis , maintenance therapy , oncology , clinical endpoint , bendamustine , randomized controlled trial , progression free survival , lymphoma , surgery , chemotherapy